​ logo   text              

HOME PROJECTS AND PUBLICATIONS MEMBERSHIP For Members only ABOUT US CONTACT US

 

 

coordinating office:

Professor R-O.Mirimanoff

Professor E.M. Ozsahin

administrator:

Delphine Mariel

Department of Radiation

Oncology, Centre Hospitalier

Universitaire Vaudois (CHUV)

Rue du Bugnon 46, CH-1011 LAUSANNE, Switzerland 

 

© RCN 2004-2016
webmaster@rarecancer.net

New RCN site is under conatruction!!!

bada.jpg

RCN Meeting

May 17th and 18th, 2018

Badalona

Barcelona

The Meeting scientific program is here.

 

rt_mini

 Letter from the Editor, to members of the Rare Cancer Network.

 

Dear Colleagues,

 

I would like to draw your attention to the journal Rare Tumors, when you consider publication of studies and case reports in the field of rare cancers and benign neoplasms. Rare Tumors is an online, open access, peer-reviewed journal focused on the study of rare tumors. The journal's editorial policy was directly inspired by the past work of the Rare Cancer Network. You will see the content of Volume Six at this link.

 

Since the launch of the journal, we have received 115 manuscript submissions, of which 72% of those reviewed to date have been accepted for publication. The average time for completion of peer review is 35 days.

 

We will soon be launching a series of invited commentaries on the "problem" of studying rare tumors in an era of evidence-based medical research. If you are interested in writing on this topic, please contact me directly for more details.

 

Robert C. Miller MD

Editor in Chief, Rare Tumors

miller.robert@mayo.edu

 

Uupdated by Myroslav Lutsyk for the last time: 10 April 2018

  • AUSTRALIA
  • AUSTRIA
  • BELGIUM
  • BRAZIL
  • CANADA
  • CHILE
  • CHINA
  • COLOMBIA
  • DENMARK
  • FRANCE
  • GERMANY
  • GREECE
  • ISRAEL
  • ITALY
  • MOROCCO
  • THE NETHERLANDS
  • POLAND
  • SAUDI ARABIA
  • SPAIN
  • SWEDEN
  • SWITZERLAND
  • TURKEY
  • UNITED KINGDOM
  • USA